*N-Formyl Trimetazidine
| Product Name | *N-Formyl Trimetazidine |
|---|---|
| Alternate Names | Trimetazidine Impurities, Impurities of Trimetazidine |
| CAT No. | CS-T-24773 |
| CAS No. | 92700-82-8 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 294.35 g/mol |
| Mol. For. | C15H22N2O4 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Trimetazidine |
| Purity | Not less than 95% |
| Smileys | COC1=C(C(=C(C=C1)CN2CCN(CC2)C=O)OC)OC |
| Canonical Smiles | COC1=C(C(=C(C=C1)CN2CCN(CC2)C=O)OC)OC |
| InchIKey | QHURJNCDEVRNDT-UHFFFAOYSA-N |
| Inchl | InChI=1S/C15H22N2O4/c1-19-13-5-4-12(14(20-2)15(13)21-3)10-16-6-8-17(11-18)9-7-16/h4-5,11H,6-10H2,1-3H3 |
| IUPAC | 4-[(2,3,4-trimethoxyphenyl)methyl]piperazine-1-carbaldehyde |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
N-Formyl Trimetazidine is a chemical compound that has been found to have potential therapeutic uses in the treatment of cardiovascular disease. It is a derivative of Trimetazidine, a drug that is commonly used to treat angina pectoris, a type of chest pain that occurs due to reduced blood flow to the heart. N-Formyl Trimetazidine has been shown to exhibit stronger anti-ischemic effects than its parent compound, making it a promising candidate for treating heart disease.
The chemical structure of N-Formyl Trimetazidine includes a formyl group, which is a functional group consisting of a carbonyl group bonded to a hydrogen atom. This gives the compound unique properties that make it more potent than Trimetazidine. It is believed that the formyl group in N-Formyl Trimetazidine may interact with specific receptors in the heart, resulting in improved blood flow and reduced ischemia.
The usage of N-Formyl Trimetazidine is being investigated in preclinical studies, and its safety and efficacy have yet to be established in humans. However, initial results have been promising, and it is hoped that this compound could become a valuable addition to the arsenal of drugs used to treat cardiovascular disease. Further studies are needed to determine the optimal dosage and administration of N-Formyl Trimetazidine, as well as its potential side effects and interactions with other medications.
Get an Instant Quote
Related Compounds
Trimetazidine Hydrochloride Impurity E | TRIMETAZIDINE IMPURITY-H | N-Nitroso Trimetazidine HCl Salt | Trimetazidine Hydrochloride Impurity H | Trimetazidine Dihydrochloride Impurity A Dihydrochloride | Trimetazidine Dihydrochloride Impurity I | Trimetazidine N-Oxide | Trimetazidine Hydrochloride Impurity B | N-Nitroso-TRIMETAZIDINE | N-Methyl Trimetazidine Dihydrochloride |